A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
(Q51833179)
scientific article published in February 2009
scientific article published in February 2009
Language: